These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1535159

  • 1. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.
    Fuxe K, O'Connor WT, Antonelli T, Osborne PG, Tanganelli S, Agnati LF, Ungerstedt U.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5591-5. PubMed ID: 1535159
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
    Ferraro L, O'Connor WT, Antonelli T, Fuxe K, Tanganelli S.
    Eur J Neurosci; 1997 Sep 15; 9(9):1838-46. PubMed ID: 9383206
    [Abstract] [Full Text] [Related]

  • 3. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 4. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 11; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 5. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 6. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 7. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 9. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation.
    Steinberg R, Souilhac J, Rodier D, Alonso R, Emonds-Alt X, Le Fur G, Soubrié P.
    Neuroscience; 1998 May 10; 84(2):511-8. PubMed ID: 9539221
    [Abstract] [Full Text] [Related]

  • 10. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 10; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 11. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG, Qu H, Bourke CH, Iuvone PM, Dobner PR, Nemeroff CB, Kinkead B.
    Behav Brain Res; 2015 Mar 01; 280():160-71. PubMed ID: 25449842
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O, Roncada P, Dall'Olio R, Montanaro N.
    Brain Res; 1988 Jul 12; 455(2):390-3. PubMed ID: 2969768
    [Abstract] [Full Text] [Related]

  • 13. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.
    Li XM, Ferraro L, Tanganelli S, O'Connor WT, Hasselrot U, Ungerstedt U, Fuxe K.
    J Neural Transm Gen Sect; 1995 Jul 12; 102(2):125-37. PubMed ID: 8748677
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.
    Saller CF, Salama AI.
    Eur J Pharmacol; 1985 Feb 26; 109(2):297-300. PubMed ID: 3873343
    [Abstract] [Full Text] [Related]

  • 15. Neurotensin increases extracellular striatal dopamine levels in vivo.
    Chapman MA, See RE, Bissette G.
    Neuropeptides; 1992 Jul 26; 22(3):175-83. PubMed ID: 1436404
    [Abstract] [Full Text] [Related]

  • 16. The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study.
    Rimondini R, O'Connor WT, Sillard R, Mutt V, Ungerstedt U, Fuxe K.
    Regul Pept; 1996 Feb 22; 61(2):111-7. PubMed ID: 8852813
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
    Harte M, O'Connor WT.
    Brain Res; 2004 Aug 13; 1017(1-2):120-9. PubMed ID: 15261107
    [Abstract] [Full Text] [Related]

  • 18. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Aug 13; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 19. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z, Fuxe K, Narváez JA, Finetti S, Antonelli T, Tanganelli S, Ferraro L.
    Neuroreport; 2002 May 07; 13(6):763-6. PubMed ID: 11997683
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT, Threlkeld PG, Bymaster FP.
    Arzneimittelforschung; 1993 Apr 07; 43(4):409-12. PubMed ID: 7684223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.